Oligonucleotide mediated reversal of drug resistance
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 27, 2002
Issued Date -
N/A
app pub date -
Nov 12, 1996
filing date -
Nov 17, 1995
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention provides methods of resensitizing an anti-drug-resistant infectious agent to a drug. Also disclosed are synthetic oligonucleotides having a nucleotide sequence complementary to a region of pfmdr1 nucleic acid, and methods of down-regulating the expression of pfmdr nucleic acid using such oligonucleotides.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully